Opus Genetics, Inc (IRD) insider trading
Every open-market stock purchase and sale by Opus Genetics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Foundation Fighting Blindness Retinal Degeneration Fund (Director) and 4 others sold $3M in the last 90 days.
- Last insider buy: Cam Gallagher (Insider), $163K, 10 months ago.
Last 12 months: insiders bought $324K (1 buy) and sold $19.3M (18 sales). Last close $3.82 on Oct 22, 2026.
Recent IRD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 30, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund (Director) | Sold | $2.8M |
| Sep 9, 2026 | George Magrath (CEO) | Bought (not open market) | $451K |
| Sep 9, 2026 | George Magrath (CEO) | Sold (not open market) | $451K |
| Sep 9, 2026 | George Magrath (CEO) | Bought (not open market) | — |
| Sep 8, 2026 | Cam Gallagher (Insider) | Bought (not open market) | $902K |
| Sep 8, 2026 | Cam Gallagher (Insider) | Bought (not open market) | — |
| Sep 3, 2026 | Robert E. Gagnon (CFO) | Sold | $127K |
| Jul 23, 2026 | George Magrath (CEO) | Sold | $27.9K |
| Jul 23, 2026 | Robert E. Gagnon (CFO) | Sold | $22.9K |
| Jul 23, 2026 | Benjamin R Yerxa (President) | Sold | $22.1K |
| Jul 23, 2026 | Joseph K Schachle (COO) | Sold | $13.7K |
| May 18, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund (Director) | Sold | $7.4M |
| Apr 23, 2026 | George Magrath (CEO) | Sold | $49.6K |
| Apr 23, 2026 | Robert E. Gagnon (CFO) | Sold | $40.7K |
| Apr 23, 2026 | Ashwath Jayagopal (Officer) | Sold | $39.2K |
| Apr 23, 2026 | Benjamin R Yerxa (President) | Sold | $39.1K |
| Apr 23, 2026 | Joseph K Schachle (COO) | Sold | $24.5K |
| Apr 23, 2026 | Rabourn Amy Zaremba (Insider) | Sold | $8.5K |
| Apr 20, 2026 | Sean Ainsworth (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Jean Bennett (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Susan Benton (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Cam Gallagher (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Adrienne L Graves (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | James S J Manuso (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Richard J Rodgers (Insider) | Bought (not open market) | — |
Who's trading IRD
- Foundation Fighting Blindness Retinal Degeneration Fund, Director: sold $18.8M (3 sales), last Sep 30, 2026
- George Magrath, CEO: sold $205K (3 sales), last Sep 9, 2026
- Cam Gallagher, Insider: bought $324K (2 buys), last Sep 8, 2026
- Robert E. Gagnon, CFO: sold $191K (3 sales), last Sep 3, 2026
- Benjamin R Yerxa, President: sold $61.2K (2 sales), last Jul 23, 2026
- Joseph K Schachle, COO: sold $57.7K (3 sales), last Jul 23, 2026
- Rabourn Amy Zaremba, Insider: sold $23.3K (2 sales), last Apr 23, 2026
- Ashwath Jayagopal, Officer: sold $58.2K (2 sales), last Apr 23, 2026
- Sean Ainsworth, Insider: other filings, last Apr 20, 2026
- Susan Benton, Insider: other filings, last Apr 20, 2026
- Jean Bennett, Insider: other filings, last Apr 20, 2026
- James S J Manuso, Insider: other filings, last Apr 20, 2026
- Adrienne L Graves, Insider: other filings, last Apr 20, 2026
- Richard J Rodgers, Insider: other filings, last Apr 20, 2026
Get free alerts when an insider at Opus Genetics, Inc files a new trade →